Efektivitas Probiotik Lactobacillus dalam Penanganan dan Pencegahan Kekambuhan Bacterial Vaginosis pada Perempuan : Systematic Review

Authors

  • Ngakan Putu Ngurah Raditya Indrasta Universitas Pendidikan Ganesha
  • Putu Marsya Febi Sabrina Putri Universitas Pendidikan Ganesha
  • Putu Sudarsana Universitas Pendidikan Ganesha
  • Luh Ari Arini Universitas Pendidikan Ganesha
  • I Wayan Natha Wiguna Universitas Pendidikan Ganesha

DOI:

https://doi.org/10.54259/sehatrakyat.v5i4.9167

Keywords:

Bacterial Vaginosis, Vaginal Microbiota, Recurrence, Probiotics, Lactobacillus

Abstract

Bacterial vaginosis (BV) is a vaginal microbiota disorder marked by an inequality in the normal vaginal flora and a reduced dominance of Lactobacillus. Lactobacillus-based probiotics have the capability to reinstate vaginal microbiota and prevent BV recurrence. This systematic review aimed to evaluate the effectiveness of Lactobacillus-based probiotics in the treatment and prevention of BV recurrence in women. A literature search was conducted across several databases for articles published between 2021 and 2025. Studies were selected based on predefined inclusion and exclusion criteria, and methodological quality was assessed using the Joanna Briggs Institute Critical Appraisal Checklist. Of the 204 records identified, 10 studies met the eligibility criteria and were included in the synthesis. All studies used randomized controlled trial or controlled clinical trial designs, with sample sizes ranging from 43 to 716 women. Overall, Lactobacillus-based probiotics demonstrated benefits in improving vaginal microbiota and showed potential for reducing BV recurrence. However, the effectiveness across studies was not entirely consistent and was influenced by factors such as probiotic strain, dosage, route of administration, treatment duration, and population characteristics. Lactobacillus-based probiotics may be used as an additional therapy for the treatment and prevention of BV recurrence, particularly after standard antibiotic treatment. However, probiotics cannot yet replace antibiotic therapy due to the limited and inconsistent evidence currently available.

Downloads

Download data is not yet available.

References

Abavisani M, Sahebi S, Dadgar F, Peikfalak F, Keikha M. The role of probiotics as adjunct treatment in the prevention and management of gynecological infections: An updated meta-analysis of 35 RCT studies. Taiwan J Obstet Gynecol. 2024 May 1;63(3):357–68. doi:10.1016/J.TJOG.2024.03.004 PubMed PMID: 38802199.

Ahire, J. J., Sahoo, S., Kashikar, M. S., Heerekar, A., Lakshmi, S. G., & Madempudi, R. S. (2023). In Vitro Assessment of Lactobacillus crispatus UBLCp01, Lactobacillus gasseri UBLG36, and Lactobacillus johnsonii UBLJ01 as a Potential Vaginal Probiotic Candidate. Probiotics and antimicrobial proteins, 15(2), 275–286. https://doi.org/10.1007/s12602-021-09838-9

Armstrong E, Hemmerling A, Miller S, Burke KE, Newmann SJ, Morris SR, et al. Sustained effect of LACTIN-V (Lactobacillus crispatus CTV-05) on genital immunology following standard bacterial vaginosis treatment: results from a randomised, placebo-controlled trial. Lancet Microbe. 2022 Jun 1;3(6):e435–42. doi:10.1016/S2666-5247(22)00043-X

Aw Wan Yi, Sudigdoadi, S., & Susiarno, H. (2019). The bacterial vaginosis among pregnant women in Jatinangor. Althea Medical Journal, 6(4), 186–191. https://doi.org/10.15850/amj.v6n4.1760

Bangar S, Sonar P, Mane A, Sane S, Kadam A, Katendra TL, et al. Prevention of recurrence of bacterial vaginosis using lactobacilli-containing vaginal tablets among women with HIV: a randomized, placebo-controlled, double-blinded phase IV trial. Int J Infect Dis. 2023 Apr 1;129:197–204. doi:10.1016/J.IJID.2023.02.003 PubMed PMID: 36773716.

Bhujel, R., Mishra, S. K., Yadav, S. K., Bista, K. D., & Parajuli, K. (2021). Comparative study of Amsel’s criteria and Nugent scoring for diagnosis of bacterial vaginosis in a tertiary care hospital, Nepal. BMC Infectious Diseases, 21, 825. https://doi.org/10.1186/s12879-021-06562-1

Chen R, Li R, Qing W, Zhang Y, Zhou Z, Hou Y, et al. Probiotics are a good choice for the treatment of bacterial vaginosis: a meta-analysis of randomized controlled trial. Reprod Health. 2022 Dec 1;19(1):137-. doi:10.1186/S12978-022-01449-Z/TABLES/2 PubMed PMID: 35698149.

Chieng WK, Abdul Jalal MI, Bedi JS, Zainuddin AA, Mokhtar MH, Abu MA, et al. Probiotics, a promising therapy to reduce the recurrence of bacterial vaginosis in women? a systematic review and meta-analysis of randomized controlled trials. Front Nutr. 2022 Sep 20;9:938838. doi:10.3389/FNUT.2022.938838/FULL

Cohen, C. R., Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., & Hemmerling, A. (2020). Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis. The New England journal of medicine, 382(20), 1906–1915. https://doi.org/10.1056/NEJMoa1915254

He, Y., Niu, X., Wang, B., Na, R., Xiao, B., & Yang, H. (2020). Evaluation of the Inhibitory Effects of Lactobacillus gasseri and Lactobacillus crispatus on the Adhesion of Seven Common Lower Genital Tract Infection-Causing Pathogens to Vaginal Epithelial Cells. Frontiers in medicine, 7, 284. https://doi.org/10.3389/fmed.2020.00284

Lin TC, Hsu IL, Tsai WH, Chu YC, Kuan LC, Huang MS, et al. Improvement of Bacterial Vaginosis by Oral Lactobacillus Supplement: A Randomized, Double-Blinded Trial. Applied Sciences 2021, Vol 11, Page 902. 2021 Jan 20;11(3):902. doi:10.3390/APP11030902

Lokken, E. M., Manhart, L. E., Kinuthia, J., Hughes, J. P., Jisuvei, C., Mwinyikai, K., Muller, C. H., Mandaliya, K., Jaoko, W., & McClelland, R. S. (2021). Association between bacterial vaginosis and fecundability in Kenyan women planning pregnancies: a prospective preconception cohort study. Human reproduction (Oxford, England), 36(5), 1279–1287. https://doi.org/10.1093/humrep/deab002

Mändar R, Sõerunurk G, Štšepetova J, Smidt I, Rööp T, Kõljalg S, et al. Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial. Benef Microbes. 2023;14(2):143–52. doi:10.3920/BM2022.0091 PubMed PMID: 36856121.

Marcotte, H., Larsson, P. G., Andersen, K. K., Zuo, F., Mikkelsen, L. S., Brandsborg, E., Gray, G., Laher, F., & Otwombe, K. (2019). An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis. BMC infectious diseases, 19(1), 824. https://doi.org/10.1186/s12879-019-4425-1

Mbulawa, Z. Z. A., & Mabunda, S. A. (2026). Bacterial vaginosis associated with high rates of sexually transmitted infections among South African adolescent girls and young women. Infection, 54(1), 213–224. https://doi.org/10.1007/s15010-025-02649-y

O'Hanlon, D. E., Come, R. A., & Moench, T. R. (2019). Vaginal pH measured in vivo: lactobacilli determine pH and lactic acid concentration. BMC microbiology, 19(1), 13. https://doi.org/10.1186/s12866-019-1388-8

Park SH, Lee ES, Park ST, Jeong SY, Yun Y, Kim YG, et al. Efficacy and Safety of MED-01 Probiotics on Vaginal Health: A 12-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients. 2023 Jan 1;15(2). doi:10.3390/NU15020331 PubMed PMID: 36678202.

Peebles, K., Velloza, J., Balkus, J. E., McClelland, R. S., & Barnabas, R. V. (2019). High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-Analysis. Sexually transmitted diseases, 46(5), 304–311. https://doi.org/10.1097/OLQ.0000000000000972

Qi F, Fan S, Fang C, Ge L, Lyu J, Huang Z, et al. Orally administrated Lactobacillus gasseri TM13 and Lactobacillus crispatus LG55 can restore the vaginal health of patients recovering from bacterial vaginosis. Front Immunol. 2023 Jul 27;14:1125239. doi:10.3389/FIMMU.2023.1125239/TEXT PubMed PMID: 37575226.

Qian, Z., Zhu, H., Zhao, D., Yang, P., Gao, F., Lu, C., Yin, Y., Kan, S., & Chen, D. (2021). Probiotic Lactobacillus sp. Strains Inhibit Growth, Adhesion, Biofilm Formation, and Gene Expression of Bacterial Vaginosis-Inducing Gardnerella vaginalis. Microorganisms, 9(4), 728. https://doi.org/10.3390/microorganisms9040728

Rezazadeh MB, Zanganeh M, Jarahi L, Fatehi Z. Comparative efficacy of oral and vaginal probiotics in reducing the recurrence of bacterial vaginosis: a double-blind clinical trial. BMC Womens Health. 2024 Dec 1;24(1):575-. doi:10.1186/S12905-024-03418-Z/TABLES/2 PubMed PMID: 39462408.

Udjianto U, Sirat NA, Rahardjo B, Zuhriyah L. Effective probiotic regimens for bacterial vaginosis treatment and recurrence prevention: A systematic review. Narra J. 2025 Mar 10;5(1):e1671–e1671. doi:10.52225/NARRA.V5I1.1671

Vaccalluzzo A, Pino A, Grimaldi RL, Caggia C, Cianci S, Randazzo CL. Lacticaseibacillus rhamnosus TOM 22.8 (DSM 33500) is an effective strategy for managing vaginal dysbiosis, rising the lactobacilli population. J Appl Microbiol. 2024 May 1;135(5). doi:10.1093/JAMBIO/LXAE110 PubMed PMID: 38755019.

Zhang R, Liu Z, Zhang Y, Mi L, Zhang D, Li Y, et al. Probiotics reduce the recurrence of asymptomatic bacterial vaginosis in Chinese women. Sci Rep. 2025 Dec 1;15(1):9689. doi:10.1038/S41598-025-92843-7 PubMed PMID: 40113887.

Zhang Y, Lyu J, Ge L, Huang L, Peng Z, Liang Y, et al. Probiotic Lacticaseibacillus rhamnosus GR-1 and Limosilactobacillus reuteri RC-14 as an Adjunctive Treatment for Bacterial Vaginosis Do Not Increase the Cure Rate in a Chinese Cohort: A Prospective, Parallel‐Group, Randomized, Controlled Study. Front Cell Infect Microbiol. 2021 Jul 6;11:669901. doi:10.3389/FCIMB.2021.669901/FULL PubMed PMID: 34295831.

Downloads

Published

2026-11-15

How to Cite

Ngakan Putu Ngurah Raditya Indrasta, Putu Marsya Febi Sabrina Putri, Putu Sudarsana, Luh Ari Arini, & I Wayan Natha Wiguna. (2026). Efektivitas Probiotik Lactobacillus dalam Penanganan dan Pencegahan Kekambuhan Bacterial Vaginosis pada Perempuan : Systematic Review. Sehat Rakyat: Jurnal Kesehatan Masyarakat, 5(4), 2071–2084. https://doi.org/10.54259/sehatrakyat.v5i4.9167